Statistics
Publications
11
Citations
3.3K
H-Index
11
Active since
2004
Louis V. LaFrance is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.
Publications per year
2004–2022
11
11
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations
Holly K. Koblish, Shuyuan Zhao, Carol F. Franks et al. · Molecular Cancer Therapeutics · 2006 · 164 citations · Full text
1–5 of 11